When plaque builds up in a coronary artery, it can narrow the artery. This reduces the flow of blood to the heart, which can cause a heart attack. If diagnosed early, in such situations, a stent is ...

Oct 30 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive it in your inbox for free sign up here, opens new ...

CONCORD, Calif. (KGO) -- Research being conducted here in the Bay Area could provide a major advance for heart patients. Surgeons at John Muir Medical Center in Concord are implanting patients with a ...

A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents a patient may need, making it a safe and effective way to treat certain ...

Philadelphia, February 20, 2025 – Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature.

Elixir Medical’s coronary implant, DynamX bioadaptor, has been proven to significantly reduce the risk of device-related cardiac events compared with current-generation drug-eluting stents in a ...

A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents ...

CINCINNATI (WKRC) - A new heart therapy, known as the Watchman, is offering hope to patients with atrial fibrillation who are seeking alternatives to medication. The TriHealth Heart and Vascular ...

GAITHERSBURG, Maryland (Reuters) - Medtronic Inc's drug-coated Endeavor heart stent won unanimous support on Wednesday from U.S. advisers who said the device appeared safe and effective based on ...

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure. While routine ...

TRiCaresAnnouncesSuccessfulImplantationofMinimallyInvasiveTopazTricuspidHeartValveReplacementSystemin Patient with a Pacemaker Paris, France and Munich, Germany ...

Add Yahoo as a preferred source to see more of our stories on Google. Elixir Medical's DynamX bioadaptor has been shown to diminish target lesion failure (TLF) by 48% in a landmark clinical trial.